1672-2809
2009 Issue 5
Evaluation and prospect of chemical therapeutic drug of primary hepatocellular carcinoma
WANG Ge;ZHANG Zhi-min
WANG Ge;ZHANG Zhi-min
..............page:169-172
Application status of Xingnaojing Injection in treating nerve system diseases
DENG Li-ying;LEI Ming
DENG Li-ying;LEI Ming
..............page:173-176
Study progress in Condyceps sinensis and its mycelia preparation against liver fibrosis mechanisms
LI Yu-jiao;XU Fang-yun
LI Yu-jiao;XU Fang-yun
..............page:203-206
Dangerous factor and prognostic analysis on portal vein cancer thrombosis of primary hepatocellular carcinoma
OUYANG Yang;ZHANG Hai-ying;ZHAI Yun
OUYANG Yang;ZHANG Hai-ying;ZHAI Yun
..............page:200-202
The effect of age, gender and alcohol consumption to pathogecy of hepatic carcinoma
SUN Xiao-yan;WANG Bing-yuan
SUN Xiao-yan;WANG Bing-yuan
..............page:197-199,189
Influences on HepG2 cell proliferation through the intervention of NF-KB activation by TNF-α monoclonal antibody
SHEN Jun-jun;YAO Deng-fu;SAI Wen-li
SHEN Jun-jun;YAO Deng-fu;SAI Wen-li
..............page:193-196
Effect of thalidomine inhibits on VEGF expression to malignant transformation of hepatocytes
GO Wen-jing;YAO Deng-fu;QIU Li-wei
GO Wen-jing;YAO Deng-fu;QIU Li-wei
..............page:190-192
Hypoxia inducible factor-1 gene and liver cancer targeted therapy
YAO Deng-fu;LI Yuo-ming;QIAN Jing
YAO Deng-fu;LI Yuo-ming;QIAN Jing
..............page:185-189
A new means of primary hepatocellular carcinoma treatment-gene therapy
ZHAI Yun;LI Ning;DING Hui-guo
ZHAI Yun;LI Ning;DING Hui-guo
..............page:181-184
Progress in the immunotherapy of primary hepatocellular carcinoma
XIANG Guo-qing;WANG Bing-yuan
XIANG Guo-qing;WANG Bing-yuan
..............page:177-180